309 related articles for article (PubMed ID: 33381880)
1. Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3.
van Lier D; Kox M; Pickkers P
J Intern Med; 2021 Jun; 289(6):792-806. PubMed ID: 33381880
[TBL] [Abstract][Full Text] [Related]
2. The value of bioactive adrenomedullin and dipeptidyl peptidase 3 to predict short-term unfavourable outcomes after cardiac surgery: A prospective cohort study.
van Lier D; Beunders R; Kox M; Pickkers P
Eur J Anaesthesiol; 2022 Apr; 39(4):342-351. PubMed ID: 35102040
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis.
Geven C; Kox M; Pickkers P
Front Immunol; 2018; 9():292. PubMed ID: 29520277
[TBL] [Abstract][Full Text] [Related]
4. Circulating Biologically Active Adrenomedullin (bio-ADM) Predicts Hemodynamic Support Requirement and Mortality During Sepsis.
Caironi P; Latini R; Struck J; Hartmann O; Bergmann A; Maggio G; Cavana M; Tognoni G; Pesenti A; Gattinoni L; Masson S;
Chest; 2017 Aug; 152(2):312-320. PubMed ID: 28411114
[TBL] [Abstract][Full Text] [Related]
5. Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study.
Blet A; Deniau B; Santos K; van Lier DPT; Azibani F; Wittebole X; Chousterman BG; Gayat E; Hartmann O; Struck J; Bergmann A; Antonelli M; Beishuizen A; Constantin JM; Damoisel C; Deye N; Di Somma S; Dugernier T; François B; Gaudry S; Huberlant V; Lascarrou JB; Marx G; Mercier E; Oueslati H; Pickkers P; Sonneville R; Legrand M; Laterre PF; Mebazaa A;
Crit Care; 2021 Feb; 25(1):61. PubMed ID: 33588925
[TBL] [Abstract][Full Text] [Related]
6. Novel Methods for the Quantification of Dipeptidyl Peptidase 3 (DPP3) Concentration and Activity in Human Blood Samples.
Rehfeld L; Funk E; Jha S; Macheroux P; Melander O; Bergmann A
J Appl Lab Med; 2019 May; 3(6):943-953. PubMed ID: 31639686
[TBL] [Abstract][Full Text] [Related]
7. Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness.
Lundberg OHM; Lengquist M; Spångfors M; Annborn M; Bergmann D; Schulte J; Levin H; Melander O; Frigyesi A; Friberg H
Crit Care; 2020 Nov; 24(1):636. PubMed ID: 33148300
[TBL] [Abstract][Full Text] [Related]
8. Vascular Effects of Adrenomedullin and the Anti-Adrenomedullin Antibody Adrecizumab in Sepsis.
Geven C; Bergmann A; Kox M; Pickkers P
Shock; 2018 Aug; 50(2):132-140. PubMed ID: 29324626
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2).
Geven C; Blet A; Kox M; Hartmann O; Scigalla P; Zimmermann J; Marx G; Laterre PF; Mebazaa A; Pickkers P
BMJ Open; 2019 Feb; 9(2):e024475. PubMed ID: 30782906
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl peptidase 3 modulates the renin-angiotensin system in mice.
Jha S; Taschler U; Domenig O; Poglitsch M; Bourgeois B; Pollheimer M; Pusch LM; Malovan G; Frank S; Madl T; Gruber K; Zimmermann R; Macheroux P
J Biol Chem; 2020 Oct; 295(40):13711-13723. PubMed ID: 32546481
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of dipeptidyl peptidase 3 in pathophysiology.
Malovan G; Hierzberger B; Suraci S; Schaefer M; Santos K; Jha S; Macheroux P
FEBS J; 2023 May; 290(9):2246-2262. PubMed ID: 35278345
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin in heart failure: pathophysiology and therapeutic application.
Voors AA; Kremer D; Geven C; Ter Maaten JM; Struck J; Bergmann A; Pickkers P; Metra M; Mebazaa A; Düngen HD; Butler J
Eur J Heart Fail; 2019 Feb; 21(2):163-171. PubMed ID: 30592365
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock.
Nishio K; Akai Y; Murao Y; Doi N; Ueda S; Tabuse H; Miyamoto S; Dohi K; Minamino N; Shoji H; Kitamura K; Kangawa K; Matsuo H
Crit Care Med; 1997 Jun; 25(6):953-7. PubMed ID: 9201046
[TBL] [Abstract][Full Text] [Related]
14. Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients.
Dépret F; Amzallag J; Pollina A; Fayolle-Pivot L; Coutrot M; Chaussard M; Santos K; Hartmann O; Jully M; Fratani A; Oueslati H; Cupaciu A; Benyamina M; Guillemet L; Deniau B; Mebazaa A; Gayat E; Farny B; Textoris J; Legrand M;
Crit Care; 2020 Apr; 24(1):168. PubMed ID: 32321571
[TBL] [Abstract][Full Text] [Related]
15. Adrenomedullin in Sepsis: Finally, a Friend or an Enemy?
Ajith Kumar AK
Indian J Crit Care Med; 2020 Dec; 24(12):1151-1153. PubMed ID: 33446960
[TBL] [Abstract][Full Text] [Related]
16. A novel and highly efficient purification procedure for native human dipeptidyl peptidase 3 from human blood cell lysate.
Kaufmann P; Muenzner M; Kästorf M; Santos K; Hartmann T; Dienelt A; Rehfeld L; Bergmann A
PLoS One; 2019; 14(8):e0220866. PubMed ID: 31390378
[TBL] [Abstract][Full Text] [Related]
17. Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock:
van Lier D; Picod A; Marx G; Laterre PF; Hartmann O; Knothe C; Azibani F; Struck J; Santos K; Zimmerman J; Bergmann A; Mebazaa A; Pickkers P
Front Med (Lausanne); 2022; 9():1058235. PubMed ID: 36530868
[TBL] [Abstract][Full Text] [Related]
18. Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics.
Deniau B; Rehfeld L; Santos K; Dienelt A; Azibani F; Sadoune M; Kounde PR; Samuel JL; Tolpannen H; Lassus J; Harjola VP; Vodovar N; Bergmann A; Hartmann O; Mebazaa A; Blet A
Eur J Heart Fail; 2020 Feb; 22(2):290-299. PubMed ID: 31472040
[TBL] [Abstract][Full Text] [Related]
19. Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study.
van Lier D; Deniau B; Santos K; Hartmann O; Dudoignon E; Depret F; Plaud B; Laterre PF; Mebazaa A; Pickkers P
ERJ Open Res; 2023 Jan; 9(1):. PubMed ID: 36628268
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of circulating dipeptidyl-peptidase 3 restores cardiac function in a sepsis-induced model in rats: A proof of concept study.
Deniau B; Blet A; Santos K; Vaittinada Ayar P; Genest M; Kästorf M; Sadoune M; de Sousa Jorge A; Samuel JL; Vodovar N; Bergmann A; Mebazaa A; Azibani F
PLoS One; 2020; 15(8):e0238039. PubMed ID: 32853284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
